Treatment with volanesorsen (VLN) reduced triglycerides and pancreatitis in patients with familial chylomicronemia syndrome (FCS) and severe hypertriglyceridemia (sHTG) vs placebo: Results of the approach and compass studies
| Autor: | E. Bruckert, R. Geary, S.G. Hughes, S. Tsmikas, J. L. Witztum, A. Digenio, Daniel Gaudet, Erik S.G. Stroes, A. Hsieh, K. R. Williams, V. Alexander, Ioanna Gouni-Berthold, Andres Gelrud |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Severe hypertriglyceridemia medicine.medical_specialty Hepatology business.industry Endocrinology Diabetes and Metabolism Gastroenterology Familial Chylomicronemia medicine.disease Placebo 03 medical and health sciences 030104 developmental biology 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine medicine Pancreatitis In patient business |
| Zdroj: | Pancreatology. 18:S101 |
| ISSN: | 1424-3903 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect